Association of Serum Bicarbonate With Risk of Renal and Cardiovascular Outcomes in CKD: A Report From the Chronic Renal Insufficiency Cohort (CRIC) Study

作者：Dobre Mirela^*; Yang Wei; Chen Jing; Drawz Paul; Hamm L Lee; Horwitz Edward; Hostetter Thomas; Jaar Bernard; Lora Claudia M; Nessel Lisa; Ojo Akinlolu; Scialla Julia; Steigerwalt Susan; Teal Valerie; Wolf Myles; Rahman Mahboob

来源：American Journal of Kidney Diseases, 2013, 62(4): 670-678.

DOI：10.1053/j.ajkd.2013.01.017

• Metabolic acidosis
• serum bicarbonate
• chronic kidney disease
• cardiovascular morbidity

Background: The purpose of this study is to evaluate serum bicarbonate level as a risk factor for renal outcomes, cardiovascular events, and mortality in patients with chronic kidney disease (CKD). %26lt;br%26gt;Study Design: Observational cohort study. Setting %26 Participants: 3,939 participants with CKD stages 2-4 who enrolled in the Chronic Renal Insufficiency Cohort (CRIC) between June 2003 and December 2008. %26lt;br%26gt;Predictor: Serum bicarbonate level. %26lt;br%26gt;Outcomes: Renal outcomes, defined as end-stage renal disease (either initiation of dialysis therapy or kidney transplantation) or 50% reduction in estimated glomerular filtration rate (eGFR); atherosclerotic events (myocardial infarction, stroke, or peripheral arterial disease); congestive heart failure events; and death. %26lt;br%26gt;Measurements: Time to event. %26lt;br%26gt;Results: Mean eGFR was 44.8 +/- 16.8 (SD) mL/min/1.73 m(2), and median serum bicarbonate level was 24 (IQR, 22-26) mEq/L. During a median follow-up of 3.9 years, 374 participants died, 767 had a renal outcome, 332 experienced an atherosclerotic event, and 391 had a congestive heart failure event. In adjusted analyses, the risk of developing a renal end point was 3% lower per 1-mEq/L increase in serum bicarbonate level (HR, 0.97; 95% CI, 0.94-0.99; P = 0.01). The association was stronger for participants with eGFR %26gt; 45 mL/min/1.73 m(2) (HR, 0.91; 95% CI, 0.85-0.97; P = 0.004). The risk of heart failure increased by 14% (HR, 1.14; 95% CI, 1.03-1.26; P = 0.02) per 1-mEq/L increase in serum bicarbonate level over 24 mEq/L. Serum bicarbonate level was not associated independently with atherosclerotic events (HR, 0.99; 95% CI, 0.95-1.03; P = 0.6) and all-cause mortality (HR, 0.98; 95% CI, 0.95-1.02; P = 0.3). %26lt;br%26gt;Limitations: Single measurement of sodium bicarbonate. %26lt;br%26gt;Conclusions: In a cohort of participants with CKD, low serum bicarbonate level was an independent risk factor for kidney disease progression, particularly for participants with preserved kidney function. The risk of heart failure was higher at the upper extreme of serum bicarbonate levels. There was no association between serum bicarbonate level and all-cause mortality or atherosclerotic events.

• 出版日期2013-10